Pathophysiology of Acute Pancreatitis: Potential Application from Experimental Models and Human Medicine to Dogs

Journal of Veterinary Internal Medicine

Volumn 26, Issue 4, 2012, Pages 875-887

  Mansfield, Caroline ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Cytokine storm; Pancreatic necrosis; ROS

Indexed keywords

CYTOKINE; KALLIKREIN; KININ;

ACUTE DISEASE; ANIMAL; ANIMAL DISEASE; ARTICLE; DISEASE MODEL; DOG; DOG DISEASE; ENZYMOLOGY; INFLAMMATION; METABOLISM; PANCREATITIS; PATHOPHYSIOLOGY;

ACUTE DISEASE; ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; DOG DISEASES; DOGS; INFLAMMATION; KALLIKREINS; KININS; PANCREATITIS;

CANIS FAMILIARIS;

EID: 84864007147     PISSN: 08916640     EISSN: 19391676     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2012.00949.x     Document Type: Article

References (160)

1. Su KH, Cuthbertson C, Christophi C. Review of experimental animal models of acute pancreatitis. Hepatobiliary Pancreat Dis Int 2006;8:264-286.
2. Lasson A, Ohlsson K. Protease inhibitors in acute human pancreatitis. Scand J Gastroenterol 1984;19:779-786.
3. Windsor JA, Hammodat H. Metabolic management of severe acute pancreatitis. World J Surg 2000;24:644-672.
4. Mithofer K, Warshaw AL, Frick T, et al. Calcium administration augments pancreatic injury and ectopic trypsinogen activation after temporary systemic hypotension in rats. Anesthesiology 1995;83:1266-1273.
5. Rinderknecht H. Activation of pancreatic zymogens: normal activation, premature intrapancreatic activation, protective mechansims against inappropriate activation. Dig Dis Sci 1986;31:314-321.
6. Bhoomagoud M, Jung T, Atladottir J, et al. Reducing extracellular pH sensitizes the acinar cell to secretagogue-induced pancreatitis responses in rats. Gastoenterology 2009;137:1083-1092.
7. Noble MD, Romac J, Vigna SR, et al. A pH-sensitive, neurogenic pathway mediates disease severity in a model of post-ERCP pancreatitis. Gut 2008;57:1566-1571.
8. Keck T, Friebe V, Warshaw AL, et al. Pancreatic proteases in serum induce leukocyte-endothelial adhesion and pancreatic microcirculatory failure. Pancreatology 2005;5:241-250.
9. Bhatia M, Brady M, Shokuhi S, et al. Inflammatory mediators in acute pancreatitis. J Pathol 2000;190:117-125.
10. Frossard JL, Saluja AK, Bhagat L, et al. The role of intercellular adhesion molecule 1 and neutrophils in acute pancreatitis and pancreatitis-associated lung injury. Gastroenterology 1999;116:694-701.
11. Al Mofleh I. Severe acute pancreatitis: Pathogenic aspects and prognostic factors. World J Gastroenterol 2008;14:675-684.
12. Simpson KW, Beechey-Newman N, Lamb CR, et al. Cholecystokinin-8 induces edematous pancreatitis in dogs associated with short burst of trypsinogen activation. Dig Dis Sci 1995;40:2152-2161.
13. Lombardi B, Estes LW, Longnecker DS. Acute hemorrhagic pancreatitis (massive necrosis) with fat necrosis induced in mice by DL-ethionine fed with a choline-deficient diet. Am J Pathol 1975;79:465-480.2.
14. Niederau C, Luthen R, Niederau M, et al. Acute experimental hemorrhagic-necrotizing pancreatitis induced by feeding a choline-deficient, ethionine-supplemented diet: Methodology and standards. Eur Surg Res 1992;24(Suppl 1):40-54.
15. Hegyi P, Rakonczay Z, Sari R, et al. L-arginine-induced experimental pancreatitis. World J Gastroenterol 2004;10:2003-2009.
16. Stevens T, Conwell DL, Zuccaro G. Pathogenesis of chronic pancreatitis: An evidence-based review of past theories and recent developments. Am J Gastroenterol 2004;99:2256-2270.
17. Pfeffer RB, Stasior O, Hinton JW. The clinical picture of the sequential development of acute hemorrhagic pancreatitis in the dog. Surg Forum 1957;8:248-251.
18. Orda R, Hadas N, Orda S, et al. Experimental acute pancreatitis. Inducement by taurocholate sodium-trypsin injection into a temporarily closed duodenal loop in the rat. Arch Surg 1980;115:327-329.
19. Schmidt J, Rattner DW, Lewandrowski K, et al. A better model of acute pancreatitis for evaluating therapy. Ann Surg 1992;215:44-56.
20. Steer ML, Meldolesi J. Pathogenesis of acute pancreatitis. Annu Rev Med 1988;39:95-105.
21. Frossard J-L, Pastor CM. Experimental acute pancreatitis: New insights into the pathophyisology. Frontiers in Bioscience 2002;7:d275-d287.
22. Scheele GA. Biosynthesis, segregation and secretion of exportable proteins by the exocrine pancreas. Am J Physiol 1980;238:G467-G477.
23. Laskowski M, Kato I. Protein inhibitors of proteinases. Ann Rev Biochem 1980;49:593-626.
24. Lerch MM, Saluja AK, Dawra R, et al. Acute necrotizing pancreatitis in the opossum: Earliest morphological changes involve acinar cells. Gastoenterology 1992;103:205-213.
25. Saluja AK, Donovan E, Yamanaka K, et al. Cerulein-induced in vitro activation of trypsinogen in rat pancreatic acini is mediated by cathepsin B. Gastroenterology 1997;113:304-310.
26. Saluja AK, Steer ML. Pathophysiology of pancreatitis. Role of cytokines and other mediators of inflammation. Digestion 1999;60:27-33.
27. Halangk W, Lerch MM, Brandt-Nedelev B, et al. Role of cathepsin B in intracellular trypsinogen activation and the onset of acute pancreatitis. J Clin Invest 2000;106:773-781.
28. Steer ML, Meldolesi J, Figarella C. Pancreatitis. The role of lysosomes. Dig Dis Sci 1984;29:934-938.
29. Whitcomb DC, Gorry MC, Preston RA, et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Gen 1996;14:141-145.
30. Bishop MA, Steiner JM, Moore LE, et al. Evaluation of the cationic trypsinogen gene for potential mutations in Miniature Schnauzers with pancreatitis. Can J Vet Res 2004;68:315-318.
31. Bishop MA, Xenoulis PG, Levinski MD, et al. Identification of variants of the SPINK1 gene and their association with pancreatitis in Miniature Schnauzers. Am J Vet Res 2010;71:527-533.
32. Sherwood MW, Prior IA, Voronina SG, et al. Activation of trypsinogen in large endocytic vacuoles of pancreatic acinar cells. Proc Nat Acad Sci USA 2007;104:5674-5679.
33. Kruger B, Albrecht E, Lerch MM. The role of intracellular calcium signaling in premature protease activation and the onset of pancreatitis. Am J Pathol 2000;157:43-50.
34. Mooren FC, Hlouschek V, Finkes T, et al. Early changes in pancreatic acinar cell calcium signaling after pancreatic duct obstruction. J Biol Chem 2003;278:9361-9369.
35. Raraty M, Ward J, Erdemli G, et al. Calcium-dependent enzyme activation and vacuole formation in the apical granular region of pancreatic acinar cells. Proc Nat Acad Sci USA 2000;97:13126-13131.
36. Williams DA. The pancreas. In: Guilford WG, Center SA, Strombeck DR, et al, eds. Strombeck's Small Animal Gastroenterology. 3rd ed. Philadelphia, PA: WB Saunders, 1996;381-410.
37. Guyton AC, Hall JE. Resistance of the body to infection: I. Leukocytes, granulocytes, the monocyte-macrophage system, and inflammation In: Hall JE, ed. Textbook of Medical Physiology, 11 ed. Philadelphia, PA: Elsevier Saunders, 2006;429-438.
38. Bhatia M. The effects of neutrophil depletion on a completely noninvasive model of acute pancreatitis-associated lung injury. Int J Pancreatol 1998;24:77-83.
39. Wang XD, Wang Q, Andersson R, et al. Alteration in intestinal function in acute pancreatitis in an experimental model. Br J Surg 1996;83:1537-1542.
40. Wisner J, Green D, Ferrel L, et al. Evidence for a role of oxygen derived free radicals in the pathogenesis of cerulein induced acute pancreatitis in rats. Gut 1988;29:1516-1519.
41. Gross V, Andreesen R, Leser H-G, et al. Interleukin-8 and neutrophil activation in acute pancreatitis. Eur J Clin Invest 1992;22:200-203.
42. Makhija R, Kingsnorth AN. Cytokine storm in acute pancreatitis. J Hepato-Biliary-Pancreatic Surg 2002;9:401-410.
43. Pezzilli R. Pharmacotherapy for acute pancreatitis. Expert Opinion Pharmacother 2009;10:2999-3014.
44. Majno G, Joris I. Apoptosis, oncosis and necrosis. An overview of cell death. Am J Pathol 1995;146:3-15.
45. Anderson R, Wang X. Patterns of pancreatic cell death: Apoptosis versus oncosis. Pancreas 1998;17:281-288.
46. Bhatia M. Apoptosis of pancreatic acinar cells in acute pancreatitis: Is it good or bad? J Cell Molecular Med 2004;8:402-409.
47. Kaiser AM, Saluja AK, Sengupta A, et al. Relationship between severity, necrosis, and apoptosis in five models of experimental acute pancreatitis. Am J Physiol 1995;269:1295-1304.
48. DiMagno MJ. Nitric oxide pathways and evidence-based perturbations in acute pancreatitis. Pancreatology 2007;7:403-408.
49. Ang AD, Adhikari S, Ng SW, et al. Expression of nitric oxide synthase isoforms and nitric oxide production in acute pancreatitis and associated lung injury. Pancreatology 2009;9:150-159.
50. Dobosz M, Hac S, Mionskowska L, et al. Organ microcirculatory disturbances in experimental acute pancreatitis: A role of nitric oxide. Physiological Res 2005;54:363-368.
51. Mashimo H, Goyal RK. Lessons from genetically engineered animal models. IV. Nitric oxide synthase gene knockout mice. Am J Physiol Gastrointest Liver Physiol 1999;277:G745-G750.
52. Szabo C. Multiple pathways of peroxynitrite cytotoxicity. Toxicol Lett 2003;141:105-112.
53. Dabrowski A, Gabryelewicz A. Nitric oxide contributes to multiorgan oxidative stess in acute experimental pancreatitis. Scand J Gastroenterol 1994;29:943-948.
54. Lomis TJ, Siffring CW, Chalasani S, et al. Nitric oxide synthase inhibitors N-monomethylarginine and aminoguanidine presevent the progressive and severe hypotension associated with a rat model of pancreatitis. Am Surg 1995;61:7-10.
55. Werner J, Rivera J, Fernandez-del Castillo C, et al. Differing roles of nitric oxide in the pathogenesis of acute edematous versus necrotizing pancreatitis. Surgery 1997;121:22-30.
56. Molero X, Guarner F, Salas A, et al. Nitric oxide modulates pancreatic basal secretion and response to cerulein in the rat: Effects in acute pancreatitis. Gastoenterology 1995;108:1855-1862.
57. DiMagno MJ, Williams JA, Hao Y, et al. Endothelial nitric oxide synthase is protective in the initiation of caerulein-induced acute pancreatitis in mice. Am J Physiol Gastrointest Liver Physiol 2004;287:G80-G87.
58. Cheng S, Yan WM, Yang B, et al. A crucial role of nitric oxide in acute lung injury secondary to the acute necrotizing pancreatitis. Hum Exp Toxicol 2010;29:329-337.
59. Ueno N, Kashiwamura S, Ueda H, et al. Role of interleukin 18 in nitric oxide production and pancreatic damage during acute pancreatitis. Shock 2005;24:564-570.
60. Al-Mufti RA, Williamson RC, Mathie RT. Increased nitric oxide activity in a rat model of acute pancreatitis. Gut 1998;43:564-570.
61. Anderson HD, Rahmutula D, Gardner DG. Tumor necrosis factor inhibits endothelial nitric-oxide synthase gene promoter activity in bovine aortic endothelial cells. J Biol Chem 2004;279:963-969.
62. Long J, Song N, Liu X-P, et al. Nuclear factor-kappaB activation on the reactive oxygen species in acute necrotizing pancreatitic rats. World J Gastroenterol 2005;11:4277-4280.
63. Leindler L, Morschl E, Laszlo F, et al. Importance of cytokines, nitric oxide, and apoptosis in the pathological process of necrotizing pancreatitis in rats. Pancreas 2004;29:157-161.
64. Bhatia M, Saluja AK, Hofbauer B, et al. Role of substance P and the NK1 receptor in acute pancreatitis and pancreatitis-associated lung injury. Proc Natl Acad Sci USA 1998;95:4760-4765.
65. Que RS, Cao LP, Ding GP, et al. Correlation of nitric oxide and other free radicals with the severity of acute pancreatitis and complicated systemic inflammatory response syndrome. Pancreas 2010;39:536-540.
66. Gardner TB, Vege SS, Pearson RK, et al. Fluid resuscitation in acute pancreatitis. Clin Gastroenterol Hepatol 2008;6:1070-1076.
67. Kusterer K, Poschmann T, Friedemann A, et al. Arterial constriction, ischemia-reperfusion, and leukocyte adherence in acute pancreatitis. Am J Physiol: Gastrointestinal Liver Physiol 1993;265:G165-G171.
68. Schröder T, Kivisaari L, Standertskjold-Nordenstam C-G, et al. Pancreatic blood flow and contrast enhancement in computed tomography during experimental pancreatitis. Eur Surg Res 1985;17:286-291.
69. Klar E, Rattner DW, Compton CC, et al. Adverse effect of therapeutic vasoconstrictors in experimental acute pancreatitis. Ann Surg 1991;214:168-174.
70. Takeda K, Mikami Y, Fukuyama S, et al. Pancreatic ischemia associated with vasospasm in the early phase of human acute necrotizing pancreatitis. Pancreas 2005;30:40-49.
71. Foitzik T, Hotz HG, Schmidt J, et al. Effect of microcirculatory perfusion on distribution of trypsinogen activation peptides in acute experimental pancreatitis. Dig Dis Sci 1995;40:2184-2188.
72. Bassi D, Kollias N, Fernandez-del Castillo C, et al. Impairment of pancreatic microcirculation correlates with the severity of acute experimental pancreatitis. J Am Coll Surg 1994;179:257-263.
73. Cuthbertson CM, Christophi C. Disturbances of the microcirculation in acute pancreatitis. Br J Surg 2006;93:518-530.
74. 2-bradykinin antagonists and kallikrein inhibitors. Pharmacology 2000;60:113-120.
75. Shimizu I, Wada S, Okahisa T, et al. Radioimmunoreactive plasma bradykinin levels and histological changes during the course of cerulein-induced pancreatitis in rats. Pancreas 1993;8:220-225.
76. Thal AP, Kobold EE, Hollenberg MJ. The release of vasoactive substances in acute pancreatitis. Am J Surg 1963;105:708-713.
77. Bloechle C, Kusterer K, Kuehn RM, et al. Inhibition of bradykinin B2 receptor preserves microcirculation in experimental pancreatitis in rats. Am J Physiol: Gastrointest Liver Physiol 1998;274:G42-G51.
78. Satake K, Ha SS, Hiura A. Effects of bradykinin receptor antagonist on the release of beta-endorphin and bradykinin and on hemodynamic changes in a canine model of experimental acute pancreatitis. Pancreas 1996;12:92-97.
79. Hoffmann TF, Waldner H, Messmer K. The bradykinin antagonist CP-0597 can limit the progression of postischemic pancreatitis. Immunopharmacology 1996;33:243-246.
80. Gloor B, Stahel PF, Muller CA, et al. Predictive value of complement activation fragments C3a and sC5b-9 for development of severe disease in patients with acute pancreatitis. Scand J Gastroenterol 2003;38:1078-1082.
81. Bhatia M, Saluja AK, Singh VP, et al. Complement factor C5a exerts an anti-inflammatory effect in acute pancreatitis and associated lung injury. Am J Physiol - Gastrointest Liver Physiol 2001;280:G974-G978.
82. Hartwig W, Klafs M, Kirschfink M, et al. Interaction of complement and leukocytes in severe acute pancreatitis: Potential for therapeutic intervention. Am J Physiol: Gastrointest Liver Physiol 2006;291:G844-G850.
83. Leung PS, Chan WP, Wong TP, et al. Expression and localization of the renin-angiotensin system in the rat pancreas. J Endocrinol 1999;160:13-19.
84. Leung PS, Chan WP, Nobiling R. Regulated expression of pancreatic renin-angiotensin system in experimental pancreatitis. Mol Cell Endocrinol 2000;166:121-128.
85. Norman J. The role of cytokines in the pathogenesis of acute pancreatitis. Am J Surg 1998;175:76-83.
86. Mayer J, Rau B, Gansauge F, et al. Inflammatory mediators in human acute pancreatitis: Clinical and pathophysiological implications. Gut 2000;47:546-552.
87. Steinle A, Weidenbach H, Wagner M, et al. NF-kB/Rel activation in cerulein pancreatitis. Gastoenterology 1999;116:420-430.
88. Gukovsky I, Gukovskaya A, Blinman T, et al. Early NF-kappaB activation is associated with hormone-induced pancreatitis. Am J Physiol 1998;280:G1402-G1414.
89. Satoh A, Masamune A, Kimura K, et al. Nuclear factor kappa B expression in peripheral blood mononuclear cells of patients with acute pancreatitis. Pancreas 2003;26:350-356.
90. Norman JG, Fink GW, Denham W, et al. Tissue-specific cytokine production during experimental acute pancreatitis: A probable mechanism for distant organ dysfunction. Dig Dis Sci 1997;42:1783-1788.
91. Norman J, Fink GW, Franz MG. Acute pancreatitis induces intrapancreatic tumor necrosis factor gene expression. Arch Surg 1995;130:966-970.
92. Gukovskaya A, Gukovsky I, Zaninovic V, et al. Pancreatic acinar cells produce, release, and respond to tumor necrosis factor-alpha. Role in regulating cell death and pancreatitis. J Clin Invest 1997;100:1853-1862.
93. Norman J, Yang J, Fink GW, et al. Severity and mortality of experimental pancreatitis are dependent on interleukin-1 converting enzyme (ICE). J Interferon Cytokine Res 1997;17:113-118.
94. Rau B, Baumgart K, Paszkowski AS, et al. Clinical relevance of caspase-1 activated cytokines in acute pancreatitis: High correlation of serum interleukin-18 with pancreatic necrosis and systemic complications. Crit Care Med 2001;29:1556-1562.
95. Rau B, Paszkowski AS, Lillich S, et al. Differential effects of caspase-1/interleukin-1 beta-converting enzyme on acinar cell necrosis and apoptosis in severe experimental pancreatitis. Lab Invest 2001;81:1001-1013.
96. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996;87:2095-2147.
97. Fink GW, Norman J. Specific changes in the pancreatic expression of the interleukin 1 family of genes during experimental acute pancreatitis. Cytokine 1997;9:1023-1027.
98. Tanaka N, Murata A, Uda K, et al. Interleukin-1 receptor antagonist modifies the changes in vital organs induced by acute necrotizing pancreatitis in a rat experimental model. Crit Care Med 1995;23:901-908.
99. Norman J, Fink GW, Sexton C, et al. Transgenic animals demonstrate a role for the IL-1 receptor in regulating IL-1 beta gene expression at steady-state and during the systemic stress induced by acute pancreatitis. J Surg Res 1996;63:231-236.
100. Pezzilli R, Billi P, Miniero R, et al. Serum interleukin-6, interleukin-8, and beta 2-microglobulin in early assessment of severity of acute pancreatitis. Comparison with serum C-reactive protein. Dig Dis Sci 1995;40:2341-2348.
101. Chen CC, Wang SS, Lee F-Y, et al. Proinflammatory cytokines in early assessment of the prognosis of acute pancreatitis. Am J Gastroenterol 1999;94:213-218.
102. Leser HG, Gross V, Scheibenbogen C, et al. Elevation of serum interleukin-6 concentration precedes acute-phase response and reflects severity in acute pancreatitis. Gastroenterology 1991;101:782-785.
103. De Beaux AC, Goldie AS, Ross JA, et al. Serum concentrations of inflammatory mediators related to organ failure in patients with acute pancreatitis. Br J Surg 1996;83:349-353.
104. Rau B, Steinbach G, Gansauge F, et al. The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis. Gut 1997;41:832-840.
105. Wu BU, Johannes RS, Sun X, et al. The early prediction of mortality in acute pancreatitis: A large population-based study. Gut 2008;57:1698-1703.
106. Formela LJ, Wood LM, Whittaker M, et al. Amelioration of experimental acute pancreatitis with a potent platelet-activating factor antagonist. Br J Surg 1994;81:1783-1785.
107. Heinrich S, Schafer M, Roussan V, et al. Evidence-based treatment of acute pancreatitis: A look at established paradigms. Ann Surg 2006;243:154-168.
108. McKay CJ, Imrie CW. The continuing challenge of early mortality in acute pancreatitis. Br J Surg 2004;91:1243-1244.
109. Johnson CD, Kingsnorth AN, Imrie CW, et al. Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitis. Gut 2001;48:62-69.
110. Kusske AM, Rongione AJ, Ashley SW, et al. Interleukin-10 prevents death in lethal necrotizing pancreatitis in mice. Surgery 1996;120:284-289.
111. Van Laethem JL, Eskinazi R, Louis H, et al. Multisystemic production of interleukin 10 limits the severity of acute pancreatitis in mice. Gut 1998;43:408-413.
112. Zhang X-P, Lin Q, Zhou Y-F. Progress of study on the relationship between mediators of inflammation and apoptosis in acute pancreatitis. Dig Dis Sci 2007;52:1199-1205.
113. Gloor B, Todd KE, Lane JS, et al. Mechanism of increased lung injury after acute pancreatitis in IL-10 knockout mice. J Surg Res 1998;80:110-114.
114. Chen CC, Wang SS, Lu R-H, et al. Serum interleukin 10 and interleukin 11 in patients with acute pancreatitis. Gut 1999;45:895-899.
115. Bonecchi R, Bianchi G, Bordingnon PP, et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and TH2s. Exp Med 1998;187:129-134.
116. Takala J. Determinants of splanchnic blood flow. Br J Anaest 1996;77:50-59.
117. Rowell LB, Blackmon JR, Kenny MA, et al. Splanchnic vasomotor and metabolic adjustments to hypoxia and exercise in humans. Am J Physiol 1984;247:H251-H258.
118. Fink M. Gastrointestinal mucosal injury in experimental models of shock, trauma and sepsis. Crit Care Med 1991;19:627-641.
119. Wilmore DW, Smith RJ, O'Dwyer ST, et al. The gut: A central organ after surgical stress. Surgery 1988;104:917-923.
120. Flint RS, Windsor JA. The role of the intestine in the pathophysiology and management of severe acute pancreatitis. World J Gastroenterol 2003;5:69-85.
121. Moore EE, Moore FA, Franciose RJ, et al. The postischemic gut serves as a priming bed for circulating neutrophils that provoke multiple organ failure. J Trauma 1994;37:881-887.
122. Gonzalez RJ, Moore EE, Ciesla DJ, et al. Phospholipase A2-derived neutral lipids from posthemorrhagic shock mesenteric lymph prime the neutrophil oxidative burst. Surgery 2001;130:198-203.
123. Meakins JL, Marshall JC. The gastrointestinal tract- the motor of multiple organ failure? Arch Surg 1986;121:197-200.
124. Juvonen PO, Tenhunen JJ, Heino AA, et al. Splanchnic tissue perfusion in acute experimental pancreatitis. Scand J Gastroenterol 1999;34:308-314.
125. Bonham MJD, Abu-Zidan FM, Simovic MO, et al. Gastric intramucosal pH predicts death in severe acute pancreatitis. Br J Surg 1997;84:1670-1674.
126. Kampp M, Lundgren O, Nilsson NJ. Extravascular shunting of oxygen in the small intestine of the cat. Acta Physiol Scand 1968;72:396-403.
127. Strombeck DR. Small and large intestine: Normal structure and function In: Guilford WG, Center SA, Strombeck DR, et al, eds. Strombeck's Small Animal Gastroenterology, 3rd ed. Philadelphia, PA: WB Saunders, 1996;318-350.
128. Braganza JM. Pancreatic disease: A casualty of hepatic "detoxification"? Lancet 1983;2:1000-1002.
129. Yago MD, Martinez-Victoria E, Huertas JR, et al. Effects of the amount and type of dietary fat on exocrine pancreatic secretion in dogs after different periods of adaptation. Arch Physiol Biochem 1997;105:78-85.
130. Haig THB. Pancreatic digestive enzymes: Influence of a diet that augments pancreatitis. J Surg Res 1970;10:601-607.
131. Hess RS, Kass PH, Shofer FS, et al. Evaluation of risk factors for fatal acute pancreatitis in dogs. J Am Vet Med Assoc 1999;214:46-51.
132. Lem KY, Fosgate GT, Norby B, et al. Associations between dietary factors and pancreatitis in dogs. J Am Vet Med Assoc 2008;233:1425-1431.
133. Federico A, D'Aiuto E, Borriello F, et al. Fat: A matter of disturbance for the immune system. World J Gastroenterol 2010;16:4762-4772.
134. Radin MJ, Sharkey LC, Holycross BJ. Adipokines: A review of biological and analytical principles and an update in dogs, cats, and horses. Vet Clin Pathol 2009;38:136-156.
135. Cook AK, Breitschwerdt EB, Levine JF, et al. Risk factors associated with acute pancreatitis in dogs: 101 cases (1985-1990). J Am Vet Med Assoc 1993;203:673-679.
136. Xenoulis PG, Steiner JM. Lipid metabolism and hyperlipidemia in dogs. Vet J 2010;183:12-21.
137. Xenoulis PG, Suchodolski JS, Ruaux CG, et al. Association between serum triglyceride and canine pancreatic lipase immunoreactivity concentrations in Miniature Schnauzers. J Am Anim Hosp Assoc 2010;46:229-234.
138. Hackert T, Pfeil D, Hartwig W, et al. Platelet function in acute experimental pancreatitis induced by ischaemia-reperfusion. Br J Surg 2005;92:724-728.
139. Schwartz P, Kovak JR, Koprowski A, et al. Evaluation of prognostic factors in the surgical treatment of adrenal gland tumours in dogs: 41 cases (1999-2005). J Am Vet Med Assoc 2008;232:77-84.
140. Dervenis C, Johnson CD, Bassi C, et al. Diagnosis, objective assessment of severity, and management of acute pancreatitis. Santorini consensus statement. Int J Pancreatol 1999;25:195-210.
141. Zhang XP, Wang L, Zhou YF. The pathogenic mechanism of severe acute pancreatitis complicated with renal injury: A review of current knowledge. Dig Dis Sci 2008;53:297-306.
142. Windsor JA, Fearon KCH, Ross JA, et al. Role of serum endotoxin and antiendotoxin core antibody levels in predicting the development of multiple organ failure in acute pancreatitis. Br J Surg 1993;80:1042-1046.
143. Williams DA, Steiner JM. Canine exocrine pancreatic disease In: Ettinger SJ, Feldman EC, eds. Textbook of Veterinary Internal Medicine, 6th ed. St Louis, MO: Elsevier Saunders, 2005;1482-1488.
144. Ruaux C. Pathophysiology of organ failure in severe acute pancreatitis in dogs. Compend Contin Educ Vet 2000;22:531-542.
145. Lopez A, Lane IF, Hanna P. Adult respiratory distress syndrome in a dog with necrotizing pancreatitis. Can Vet J 1995;36:240-241.
146. Gomez Cambronero LG, Sabater L, Pereda J, et al. Role of cytokines and oxidative stress in the pathophysiology of acute pancreatitis: therapeutical implications. Cur Drug Targets Inflamm Allergy 2002;1:393-403.
147. Mansfield CS, James FE, Robertson ID. Development of a clinical severity index for dogs with acute pancreatitis. J Am Vet Med Assoc 2008;233:936-944.
148. Watson PJ, Archer J, Roulois AJ, et al. Observational study of 14 cases of chronic pancreatitis in dogs. Vet Rec 2010;167:968-976.
149. Watson PJ. Exocrine pancreatic insufficiency as an end stage of pancreatitis in four dogs. J Small Anim Pract 2003;44:306-312.
150. Boreham B, Ammori BJ. A prospective evaluation of pancreatic exocrine function in patients with acute pancreatitis: correlation with extent of necrosis and pancreatic endocrine insufficiency. Pancreatology 2003;3:303-308.
151. Pezzilli R, Simoni P, Casadei R, et al. Exocrine pancreatic function during the early recovery phase of acute pancreatitis. Hepatobiliary Pancreat Dis Int 2009;8:316-319.
152. Wiberg ME, Westermarck E. Subclinical exocrine pancreatic insufficiency in dogs. J Am Vet Med Assoc 2002;220:1183-1187.
153. Wu BU, Conwell DL. Acute pancreatitis part II: Approach to follow-up. Clin Gastroenterol Hepatol 2010;8:417-422.
154. Edwards DF, Bauer MS, Walker MA, et al. Pancreatic masses in seven dogs following acute pancreatitis. J Am Animal Hospital Assoc 1990;26:189-198.
155. Bellenger C, Ilkiw J, Malik R. Cystogastrostomy in the treatment of pancreatic pseudocyst/abscess in two dogs. Vet Rec 1989;125:181-184.
156. Johnson MD, Mann FA. Treatment for pancreatic abscesses via omentalization with abdominal closure versus open peritoneal drainage in dogs: 15 cases (1994-2004). J Am Vet Med Assoc 2006;228:397-402.
157. Salisbury SK, Lantz GC, Nelson RW, et al. Pancreatic abscess in dogs: Six cases (1978-1986). J Am Vet Med Assoc 1988;193:1104-1108.
158. Marchevsky AM, Yovich JC, Wyatt KM. Pancreatic pseudocyst causing extrahepatic biliary obstruction in a dog. Aust Vet J 2000;78:99-101.
159. Smith SA, Biller DS. Resolution of a pancreatic pseudocyst in a dog following percutaneous ultrasonographic-guided drainage. J Am Anim Hosp Assoc 1998;34:515-522.
160. VanEnkevort BA, O'Brien RT, Young KM. Pancreatic pseudocysts in 4 dogs and 2 cats: Ultrasonographic and clinicopathologic findings. J Vet Intern Med 1999;13:309-313.